94percent.com

10/14/2026

100 days in as CEO of Oxford BioDynamics ( ), Rich Compton sat down with us to share what’s surprised him and where he sees headed.

His take: Genomics has become very good at reading genomes, but much less good at explaining them. After nearly 20 years of measuring how the genome folds, OBD is well placed to help close that gap, from Explorer in the lab to Orion, our computational platform, on existing genomic data.

Read the full conversation here 👉 https://obdx.co/wa5

94percent.com

10/01/2026

Garrett D Pohlman, M.D., presented “Urology Updates” at the Nebraska Academy of Family Physicians conference ( ), highlighting how is supporting earlier, high-fidelity prostate cancer evaluation in everyday practice across rural and metropolitan Nebraska. is proud to support physicians advancing prostate cancer detection across the state.

09/10/2026

This Prostate Cancer Awareness Month, a youth football team in Maryland, just outside Washington, DC, is sharing a message with the fathers, grandfathers, coaches, and supporters on the sidelines: make time to talk about prostate health.

The Clarksburg 11U team will take the field in awareness uniforms supported by Oxford BioDynamics, helping start conversations among the adults who come together to cheer them on.

As the company behind the accurate blood test, prostate health is central to our work, and we’re pleased to support this local awareness initiative.

Thank you to the coaches and families bringing attention to an issue that touches so many lives.

Read the community story: https://mypse.co/wmi

94percent.com Joe Abdo II

08/26/2026

🎙️ New episode of The Common Sense MD: "Beyond the PSA"

Dr. Garrett Pohlman joined Dr. Tom Rogers to unpack why an elevated PSA alone doesn't tell the full story, and how a routine EpiSwitch® PSE blood test can add clarity before biopsy or imaging decisions.

"It has been a game changer in my practice." — Garrett D Pohlman, M.D.

🎧 Listen now on Apple Podcasts, Spotify, or wherever you get your podcasts:
https://youtu.be/Z1vqyGPeHBg

Oxford BioDynamics
Performance Medicine

08/13/2026

Oxford BioDynamics partners with Dubai London Clinics and Hospitals to bring to the UAE, our first commercial partnership for the prostate cancer detection test in the Gulf region. Read more: https://mypse.co/d8t

06/09/2026

A man's PSA number can climb for several reasons, often unrelated to . As a result, 3 in 4 men with a raised PSA end up with a negative biopsy. So how can you know when it really matters?

Board-certified urologist Garrett D Pohlman, M.D., uses to bring clarity before the biopsy: a routine blood test, 94% accuracy, a clearer answer.

▶️ Hear why by watching his segment on Health Uncensored with Dr. Drew at 94percent.com

Health Uncensored with Dr. Drew Oxford BioDynamics

The EpiSwitch PSE is a simple blood test that detects prostate cancer with 94% accuracy and helps avoid unnecessary biopsies and treatments.

06/01/2026

featured on Health Uncensored with Dr. Drew on Fox Business, and for good reason.

Board-certified urologist Garrett D Pohlman, M.D., joined the show to discuss how is bringing clarity to the diagnostic pathway. PSE delivers a clear, binary result with 94% accuracy from a routine blood draw, helping clinicians and patients make confident decisions before considering a biopsy.

Read the full story on our In the Loop blog: 🔗https://obdx.co/ddw

94percent.com

05/19/2026

For decades, prostate cancer screening has relied on tools that are...

05/15/2026

📅 This weekend on Health Uncensored with Dr. Drew:

A high or rising level is an anxious moment for many men, but 3 in 4 raised PSA results turn out to be due to something other than .

What comes next? This Sunday, Board-certified Urologist Dr. Garrett D Pohlman, M.D., will join Health Uncensored to share what he's seeing using the breakthrough test: a routine blood test shown to boost prostate cancer detection accuracy to 94%.

Drawing on hundreds of PSE tests ordered in his clinical practice, Dr. Pohlman will explain how the test is helping men get a clearer answer earlier, supporting better-informed clinical decisions, and safely reducing unnecessary biopsies.

📺 Tune in: Sunday 17 May, 5 pm ET on Fox Business.

Oxford BioDynamics

The EpiSwitch PSE is a simple blood test that detects prostate cancer with 94% accuracy and helps avoid unnecessary biopsies and treatments.

05/12/2026

🎬 5 days to go, and we're going behind the scenes.

Sneak peek from the green room as Board-certified Urologist Dr. Garrett D Pohlman, M.D., gets ready to join Health Uncensored with Dr. Drew on Fox Business this Sunday, 17 May.

On the agenda: the prostate cancer blood test, and what Dr. Pohlman is seeing after ordering hundreds of tests in his clinical practice. A simple blood draw is helping men get a clearer answer earlier, supporting better-informed clinical decisions, and safely reducing unnecessary biopsies.

A national conversation about accurate detection is about to hit prime time. 📺

Set your reminder: Sunday 17 May, 5pm ET on Fox Business.

Oxford BioDynamics